CSMG Technologies, Inc (fka CTGI)

[sojourner]

gotinearly: Good question. An answer could be inferred from CSMG's public statement of 02 July 2008: "Information regarding procedures using the technology and technical information regarding the technology will be removed from our web site pending FDA clearance."

To recall it, LTC president Frank D'Amelio (formerly of Gyrus AMCI) has shepherded over 200 medical devices through regulatory mazes. Thus, it's a good bet CSMG/CTGI adheres to written and unwritten rules of FDA engagement during pending 510(k) approval process, which approval allows for U.S. marketing of given LTC devices.

http://findarticles.com/p/articles/mi_m0EIN/is_/ai_n19331327
CSMG Technologies Live Tissue Connect Submits US FDA Filing
02 July 2008

CORPUS CHRISTI, Texas -- CSMG Technologies, Inc., (OTC Bulletin Board: CTUM), a technology management company focused on commercializing human live tissue bonding devices, announced that its subsidiary Live Tissue Connect, Inc. has filed a 510(K) submission with the United States Food and Drug Administration for a vessel and duct sealing electrosurgical generator and two sealing instruments.

Information regarding procedures using the technology and technical information regarding the technology will be removed from our web site pending FDA clearance.

For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.ctum.com.

Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to http://www.ctum.com/contact_information.html and fill-in information.

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

COPYRIGHT 2007 Business Wire
COPYRIGHT 2007 Gale Group